Therapeutic Efficacy of Topical Calcineurin Inhibitors in Plasma Cell Balanitis: Case Series and Review of the Literature

Publisher： Karger

E-ISSN： 1421-9832|228|1|18-23

ISSN： 1018-8665

Source： Dermatology, Vol.228, Iss.1, 2014-01, pp. : 18-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus Cream 1% for the Treatment of Papulopustular Eruption Related to Epidermal Growth Factor Receptor Inhibitors: A Case Series and a Literature Review of Therapeutic Approaches

By  

Dermatology, Vol. 220, Iss. 3, 2010-01 ,pp. : 243-248

Karger

Access to resources Recommend Favorite

Potential New Indications of Topical Calcineurin Inhibitors

By  

Dermatology, Vol. 215, Iss. 1, 2007-12 ,pp. : 45-54

Karger

Access to resources Recommend Favorite

Consensus Statement on the Safety Profile of Topical Calcineurin Inhibitors

By  

Dermatology, Vol. 211, Iss. 2, 2005-08 ,pp. : 77-78

Karger

Access to resources Recommend Favorite

Discordant Results with Pimecrolimus 1% Cream in the Treatment of Plasma Cell Balanitis

By  

Dermatology, Vol. 218, Iss. 2, 2008-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

By  

Dermatology, Vol. 211, Iss. 2, 2005-08 ,pp. : 174-187

Karger

Access to resources Recommend Favorite